PHI with Herpes simplex
How does this condition affect your private health insurance?
Herpes simplex is a common viral infection caused by the herpes simplex virus (HSV). It primarily manifests as painful blisters or sores on the skin, most commonly around the mouth (cold sores, HSV-1) or genitals (genital herpes, HSV-2). The virus is highly contagious and spreads through direct contact. After initial infection, HSV remains dormant in nerve cells and can reactivate periodically, leading to recurrent outbreaks. While not typically life-threatening, outbreaks can be uncomfortable and cause significant psychological distress. Transmission can occur even when no sores are visible.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
2 to 4 weeks
Duration of Illness (Lifetime)
Chronic with recurrent episodes
Cost of Treatment (Initial)
$50 - $300 (diagnosis and initial antiviral medication)
Cost of Treatment (Lifetime)
$200 - $1500+ (depending on frequency of outbreaks and long-term suppressive therapy)
Mortality Rate
Extremely low (virtually 0% in immunocompetent adults; higher for neonatal herpes or disseminated infection in immunocompromised individuals, <1%)
Risk of Secondary Damages
1-5% (e.g., ocular herpes leading to blindness, encephalitis, neonatal herpes, psychological impact)
Probability of Full Recovery
0% (the virus remains lifelong; however, symptoms are treatable and manageable)
Underlying Disease Risk
Low (HSV itself is the primary issue, though severe or frequent outbreaks can be a sign of underlying immunosuppression, <1%)